Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leonardo Brunetti
Observed names:
Brunetti L,
Brunetti, Leonardo,
L Brunetti,
Leonardo BRUNETTI
Institution:
University of Bari Aldo Moro
Observed institutions:
National Institutes of Health,
University of Lisbon,
University of California, San Francisco,
Magna Graecia University,
Instituto Superior Técnico,
Centro de Química Estrutural,
University of Bari Aldo Moro
show all 7
ORCID:
0000-0002-7787-6639
Observed ORCID:
0000-0002-7787-6639
OpenAlex ID:
A5086225386
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice
2005
·
Daniela Foti
, Eusebio Chiefari
, et al.
·
Nature Medicine
·
226
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy
2024
·
Vincenzo Roselli
, Gianluca Pugliese
, et al.
·
Molecules
·
57
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
2022
·
Leonardo Brunetti
, Rosalba Leuci
, et al.
·
European Journal of Medicinal Chemistry
·
52
PDF
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases
2020
·
Rosalba Leuci
, Leonardo Brunetti
, et al.
·
Foods
·
52
PDF
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
2022
·
David Vicente-Zurdo
, Noelia Rosales-Conrado
, et al.
·
Biomedicines
·
50
PDF
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding
2022
·
Leonardo Brunetti
, Rosalba Leuci
, et al.
·
Molecules
·
48
PDF
Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene.
1996
·
A Brunetti
, L Brunetti
, et al.
·
Journal of Clinical Investigation
·
41
PDF
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation
2019
·
Leonardo Brunetti
, Fulvio Loiodice
, et al.
·
Journal of Medicinal Chemistry
·
39
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents
2020
·
Rosalba Leuci
, Leonardo Brunetti
, et al.
·
Applied Sciences
·
38
PDF
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
2022
·
Alessia Carocci
, Alexia Barbarossa
, et al.
·
Antioxidants
·
33
PDF
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents
2021
·
Viviana Poliseno
, Sílvia Chaves
, et al.
·
Biomolecules
·
30
PDF
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2-Hydroxyphenylbenzimidazole-Based Scaffolds en Route to Donepezil-Like Compounds
2020
·
Luca Piemontese
, Roberta Sergio
, et al.
·
Molecules
·
26
PDF
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)
2022
·
Rosalba Leuci
, Leonardo Brunetti
, et al.
·
Molecules
·
21
PDF
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase
2022
·
Francesca Intranuovo
, Leonardo Brunetti
, et al.
·
Journal of Medicinal Chemistry
·
20
PDF
Role of copper chelating agents: between old applications and new perspectives in neuroscience
2024
·
Rosalba Leuci
, Leonardo Brunetti
, et al.
·
Neural Regeneration Research
·
18
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
2019
·
Luca Piemontese
, Leonardo Brunetti
, et al.
·
Neural Regeneration Research
·
18
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey
2024
·
Leonardo Brunetti
, Fabio Francavilla
, et al.
·
Pharmaceuticals
·
16
PDF
A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity
2022
·
Sabina Sblano
, Carmen Cerchia
, et al.
·
European Journal of Medicinal Chemistry
·
14
PDF
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
2020
·
Leonardo Brunetti
, Antonio Carrieri
, et al.
·
International Journal of Molecular Sciences
·
14
PDF
Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases
2023
·
David Vicente-Zurdo
, Leonardo Brunetti
, et al.
·
International Journal of Molecular Sciences
·
13
PDF
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition
2023
·
Antonio Laghezza
, Carmen Cerchia
, et al.
·
Journal of Medicinal Chemistry
·
12
PDF
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates
2024
·
Rosalba Leuci
, Stefan Simic
, et al.
·
Bioorganic Chemistry
·
11
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases
2024
·
Antonio Carrieri
, Alexia Barbarossa
, et al.
·
Bioorganic & Medicinal Chemistry
·
9
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect
2021
·
Francesca S. Abatematteo
, Philip D. Mosier
, et al.
·
European Journal of Medicinal Chemistry
·
7
PDF
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model
2025
·
Antonio Laghezza
, Emanuele Falbo
, et al.
·
European Journal of Medicinal Chemistry
·
6
Show more works
View as search
Works count:
48
Citation count:
970
H-index:
17
I10-index:
22
Year
Topic
Type